13G Filing: Highbridge Capital Management and Novelion Therapeutics Inc. (NVLN)

Page 2 of 6 – SEC Filing

1

NAMES OF REPORTING PERSONS

Highbridge Capital Management, LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

State of Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

1,000,000 Common Shares

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

1,000,000 Common Shares

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,000,000 Common Shares

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.39%

12

TYPE OF REPORTING PERSON

IA, OO

 

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)